Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 133

    1.

    Tracking adverse events in RCTs: lack of agreement among regulatory institutions.

    Santiago LM, Debanne SM, Neuhauser D.

    Qual Saf Health Care. 2003 Jun;12(3):234-5. No abstract available. PMID: 12792018 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Terminology for reporting adverse events updated.

    Baldwin J.

    J Natl Cancer Inst. 2003 Aug 6;95(15):1103-4. No abstract available. PMID: 12902434 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Some thoughts on the reporting of adverse events in phase II cancer clinical trials.

    Anderson SJ.

    J Clin Oncol. 2006 Aug 20;24(24):3821-2. No abstract available. PMID: 16921032 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical trials in the face of adversity.

    Clodfelter K.

    J Biolaw Bus. 2002;5(3):34-8.PMID: 12816114 [PubMed - indexed for MEDLINE]Related articles

    5.

    Detecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methods.

    Wernicke JF, Faries D, Milton D, Weyrauch K.

    Drug Saf. 2005;28(11):1057-63.PMID: 16231957 [PubMed - indexed for MEDLINE]Related articles

    6.

    Why were NIH adverse event reporting guidelines misunderstood?

    Finn R.

    J Natl Cancer Inst. 2000 May 17;92(10):784-6. No abstract available. PMID: 10814665 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    US science agencies. Top names at last.

    Anderson C.

    Nature. 1990 Sep 20;347(6290):220. No abstract available. PMID: 2402292 [PubMed - indexed for MEDLINE]Related articles

    8.

    The need for greater involvement of regulatory agencies in assessing adverse drug reactions.

    Sniderman AD.

    CMAJ. 2000 Jan 25;162(2):209-10. No abstract available. PMID: 10674055 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Three good choices.

    Koshland DE Jr.

    Science. 1993 Aug 27;261(5125):1099. No abstract available. PMID: 8356440 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical trials bureaucracy: unintended consequences of well-intentioned policy.

    Califf RM.

    Clin Trials. 2006;3(6):496-502.PMID: 17170032 [PubMed - indexed for MEDLINE]Related articles

    11.

    Numerous violations of federal informed consent requirements.

    Maloney DM.

    Hum Res Rep. 2004 Jan;19(1):1-3. No abstract available. PMID: 14997901 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gifted public servants.

    Geiduschek EP.

    Science. 1996 May 17;272(5264):937-8. No abstract available. PMID: 8638130 [PubMed - indexed for MEDLINE]Related articles

    13.

    Some concerns about adverse event reporting in randomized clinical trials.

    Yazici Y.

    Bull NYU Hosp Jt Dis. 2008;66(2):143-5.PMID: 18537786 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Bureaucrats save lives.

    Fink GR.

    Science. 1996 Mar 1;271(5253):1213. No abstract available. PMID: 8638092 [PubMed - indexed for MEDLINE]Related articles

    15.

    NSF holds plan close to its vest.

    Palca J.

    Science. 1992 Aug 14;257(5072):872. No abstract available. PMID: 1502550 [PubMed - indexed for MEDLINE]Related articles

    16.

    Health care technology.

    Sherman JF.

    J Med Educ. 1980 Feb;55(2):138-41. No abstract available. PMID: 7354485 [PubMed - indexed for MEDLINE]Related articles

    17.

    Reporting adverse events in randomized controlled trials.

    Nuovo J, Sather C.

    Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):349-51.PMID: 16998947 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cradle-to-grave records: U.S. project sets standards.

    Page D.

    Diagn Imaging (San Franc). 1999 Sep;Suppl:P5, P7. No abstract available. PMID: 10623312 [PubMed - indexed for MEDLINE]Related articles

    19.

    Gifted public servants.

    Atkins JF.

    Science. 1996 May 17;272(5264):938. No abstract available. PMID: 8638131 [PubMed - indexed for MEDLINE]Related articles

    20.

    Who should sponsor sleep disorders pharmaceutical trials?

    Kripke DF.

    J Clin Sleep Med. 2007 Dec 15;3(7):671-3. No abstract available. PMID: 18198797 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data